Saizen Articles

Genentech Granted Stop On Sales Of Norditropin

3 July 1995

Good First Quarter For Novo Nordisk

15 May 1995

- Novo Nordisk's human growth hormone product Norditropin

15 May 1995

Serono's Serostim

12 December 1994

Stronger Sales Bring Forecast Upgrade for Yamanouchi

24 October 1994

Italian Market Holds Down Ares-Serono

12 September 1994

Novo Nordisk To Build Pharma Plant In Japan

1 August 1994

BIOPHARMACEUTICALS MARKET GROWING FAST

13 June 1994

EISAI'S SALES AHEAD IN FLAT JAPANESE SECTOR

6 June 1994

NOVO NORDISK CONFIDENT, DESPITE PROFITS DOWNTURN

23 May 1994

ARES-SERONO TO CASH IN DIAGNOSTICS

16 May 1994

NET PROFITS FALL 32.7% AT ARES-SERONO

28 March 1994

GENENTECH'S hGH APPROVED IN USA

21 March 1994

ARES-SERONO LIFTS MARKET SHARE

29 November 1993

NINE-MONTH PROFITS UP 4% AT NOVO NORDISK

15 November 1993

PMA WARNING ON FUTURE OF BIOTECHNOLOGY

27 September 1993

ARES-SERONO WILL BENEFIT FROM MS MARKET

27 September 1993

EARNINGS FALL AT NOVO NORDISK

16 August 1993

ARES-SERONO PIPELINE OVERVIEW

31 May 1993

NOVO NORDISK 1st QTR AS EXPECTED

17 May 1993

NOVO NORDISK EXPANDING ITS FOCUS

26 April 1993

NOVO NORDISK TAX CUTS BENEFIT

22 March 1993

ARES-SERONO NETPROFITS LEAP 51%

15 March 1993

ARES-SERONO1992 SALES UP 16.7%

25 January 1993

NOVO NORDISK GROWTH PROSPECTS

12 October 1992

1st QTR PROFITS JUMP AT NOVO NORDISK

18 May 1992

ARES SERONO - HOW TO PLAY THE STOCK

11 May 1992

PROJECT REVIEW FROM NOVO NORDISK

27 April 1992

ARES-SERONO Rx DRUG SALES UP 15.5%

16 March 1992

NOVO REPORTS 28% PRETAX PROFIT JUMP

16 March 1992

Novo Nordisk ups 2008 guidance